Search Results 1671-1680 of 20458 for hepatitis

1. Fatigue - Mayo Clinic

   Hepatitis B and Hepatitis C: What's the difference? Hepatitis C · Hepatitis C: What happens in end-stage liver disease? Herbal treatment for anxiety: Is it ...

2. Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007) - Mayo Clinic

   - Has an active infection requiring systemic therapy. - Has a known history of human immunodeficiency virus (HIV), Hepatitis B or/and. Hepatitis C virus.

3. RAPA-501 Therapy for ALS Expanded Access Protocol - Mayo Clinic

   HIV, hepatitis B, or hepatitis C seropositive. Pregnant or breastfeeding subjects. Subjects of childbearing age, or males who have a partner of childbearing ...

4. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

   ... hepatitis C virus (anti-HCV positive). If there is a positive history of treated hepatitis B or hepatitis C, the viral load must be undetectable per ...

5. A Study to Evaluate Induction Chemotherapy with ABVD Followed by Brentuximab Vedotin Consolidation in Previously-untreated, Non-bulky Stage I or II Hodgkin Lymphoma - Mayo Clinic

   Known history of human immunodeficiency virus (HIV), hepatitis B and hepatitis C (testing is not necessary if patient does not have history of these diseases, ...

6. A Study of X4P-001 in Patients with Advanced Renal Cell Carcinoma - Mayo Clinic

   A positive test for hepatitis B surface antigen (HBsAg). Has, at screening, safety laboratory tests meeting one or more of the following criteria: Hemoglobin ...

7. A Study Of Avatrombopag For The Treatment Of Thrombocytopenia In Patients With Chronic Liver Disease Undergoing An Elective Procedure - Mayo Clinic

   Acute alcoholic hepatitis within 6 months of the study start (chronic alcoholic hepatitis is allowed); Elective procedure performed prior to visit 4 ...

8. Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Known history of HIV, hepatitis C or hepatitis B infection; Pregnancy or breast-feeding. Participating Mayo Clinic locations. Study statuses change often ...

9. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

   Known active Hepatitis B (e.g., HBsAg reactive) or Hepatitis C (e.g., HCV RNA [qualitative] is detected). Known history of active TB (Bacillus Tuberculosis) ...

10. Clinical Study Of Neflamapimod In Patients With Primary Progressive Aphasia

    Known human immunodeficiency virus, hepatitis B, or active hepatitis C virus infection. Participated in a study of an investigational drug less than 6 weeks ...